Schonherr H, Ayaz P, Taylor AM, Casaletto JB, et al. Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2. Proc Natl Acad Sci U S A 2024;121:e2317756121.
PMID: 38300868